The HIV Treat Pillar: An Update and Summary of Promising Approaches

Nanette D. Benbow*, Eve D. Mokotoff, Julia C. Dombrowski, Amy R. Wohl, Susan Scheer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

The Treat pillar of the Ending the HIV Epidemic in the U.S. plan calls for comprehensive strategies to enhance linkage to, and engagement in, HIV medical care to improve viral suppression among people with HIV and achieve the goal of 95% viral suppression by 2025. The U.S. has seen large increases in the proportion of people with HIV who have a suppressed viral load. Viral suppression has increased 41%, from 46% in 2010 to 65% in 2018. An additional increase of 46% is needed to meet the Ending the HIV Epidemic in the U.S. goal. The rate of viral suppression among those in care increased to 85% in 2018, highlighting the need to ensure sustained care for people with HIV. Greater increases in all steps along the HIV care continuum are needed for those disproportionately impacted by HIV, especially the young, sexual and racial/ethnic minorities, people experiencing homelessness, and people who inject drugs. Informed by systematic reviews and current research findings, this paper describes more recent promising practices that suggest an impact on HIV care outcomes. It highlights rapid linkage and treatment interventions; interventions that identify and re-engage people in HIV care through new collaborations among health departments, providers, and hospital systems; coordinated care and low-barrier clinic models; and telemedicine-delivered HIV care approaches. The interventions presented in this paper provide additional approaches that state and local jurisdictions can use to reach their local HIV elimination plans’ goals and the ambitious Ending the HIV Epidemic in the U.S. Treat pillar targets by 2030.

Original languageEnglish (US)
Pages (from-to)S39-S46
JournalAmerican Journal of Preventive Medicine
Volume61
Issue number5
DOIs
StatePublished - Nov 2021

Funding

The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH. Support was provided by the National Institute of Allergy and Infectious Diseases of NIH (Award Number P30 AI117943), NIH (Award Number P30 AI027757), and the National Institute on Drug Abuse of NIH (Award Number P30DA027828). NDB: Support was provided by the National Institute of Allergy and Infectious Diseases of NIH (Grant Number: P30 AI117943) and the National Institute on Drug Abuse of NIH (award number P30DA027828). JCD: Support was provided by NIH (Grant Number: P30 AI027757). No financial disclosures were reported by the authors of this paper. This article is part of a supplement entitled The Evidence Base for Initial Intervention Strategies for Ending the HIV Epidemic in the U.S. which is sponsored by the U.S. Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services (HHS). The findings and conclusions in this article are those of the author(s) and do not necessarily represent the official position of CDC or HHS. NDB: Support was provided by the National Institute of Allergy and Infectious Diseases of NIH (Grant Number: P30 AI117943) and the National Institute on Drug Abuse of NIH (award number P30DA027828). JCD: Support was provided by NIH (Grant Number: P30 AI027757). Support was provided by the National Institute of Allergy and Infectious Diseases of NIH (Award Number P30 AI117943), NIH (Award Number P30 AI027757), and the National Institute on Drug Abuse of NIH (Award Number P30DA027828).

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Epidemiology

Fingerprint

Dive into the research topics of 'The HIV Treat Pillar: An Update and Summary of Promising Approaches'. Together they form a unique fingerprint.

Cite this